Ipsen names VP, neurology
This article was originally published in Scrip
Executive Summary
New Jersey-based Ipsen Biopharmaceuticals, a specialty-driven company developing treatments for debilitating diseases, has named Donald Pearl vice-president of neurology. Mr Pearl will work closely with senior leadership to build out the neurology commercial structure in the US. He joins Ipsen from SkinMedica, an Allergan Company, where he was recently vice-president of international sales and marketing.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.